Avricore Health Partners With Ellerca Health Inc To Offer Joint Diabetes Screening and Management Support

VANCOUVER, BC – (GLOBE NEWSWIRE) – July 28, 2021 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it has signed a partnership agreement with Ellerca Health Corp to utilize their respective technologies and services to offer the most robust diabetes screening and management solutions on the market for community pharmacy. […]

HealthTab™ Adds ID NOW™ Molecular Test Device to Abbott Distribution Agreement, Now Offers First Real-Time Reporting of SARS-CoV-2, Flu, Strep and RSV System in Pharmacy

VANCOUVER, BC – (GLOBE NEWSWIRE) – July 26, 2021 – Avricore Health Inc. (TSXV:AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of the first amendment to its supplier distribution agreement between HealthTab™ Inc., a wholly owned subsidiary, and Abbott, the global healthcare company and diagnostics leader, in Canada. First […]

Beta-Testing of New HealthTab™ System in First Shoppers Drug Mart® Pharmacy Performs Well, Shows Strong Patient Demand

VANCOUVER, BRITISH COLUMBIA – July 19, 2021 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company”; or “AVCR”) announces that patient testing has begun on the first deployment of the new HealthTab™-integrated Afinion 2™ analyzers in the initial Shoppers Drug Mart® pharmacy location as part of its previously announced effort to screen for diabetes and cardiovascular […]